Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Virus or bacteriophage
Reexamination Certificate
2007-12-12
2009-12-01
Nickol, Gary B (Department: 1648)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Virus or bacteriophage
C435S005000, C435S471000, C435S235100, C424S184100, C424S410000, C426S302000
Reexamination Certificate
active
07625556
ABSTRACT:
The present invention is directed to isolated bacteriophage having strong lytic activity against strains ofE. coli, and methods of using that bacteriophage, and/or progeny or derivatives derived therefrom, to control the growth ofE. coliin various settings.
REFERENCES:
patent: 6485902 (2002-11-01), Waddell et al.
patent: 6544729 (2003-04-01), Sayler et al.
patent: 2002/0090356 (2002-07-01), Waddell et al.
patent: 2005/0175991 (2005-08-01), Sulakvelidze et al.
Wong et al., Hepatocyte Targeting of Nucleic Acid Complexes and Liposomes by a T7 Phage p17 Peptide, 2006, Molecular Pharmaceutics, vol. 3, No. 4, pp. 386-397.
Pasternack Gary R.
Sulakvelidze Alexander
Blumel Benjamin P
Hunton & Williams LLP
Intralytix, Inc.
Nickol Gary B
LandOfFree
E. coli bacteriophage and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with E. coli bacteriophage and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and E. coli bacteriophage and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4079904